---
layout: default
title: Iron
parent: Low Evidence (L5)
nav_order: 545
evidence_level: L5
indication_count: 10
---

# Iron
{: .fs-9 }

Evidence Level: **L5** | Predicted Indications: **10** 
{: .fs-6 .fw-300 }

---

## Table of Contents
{: .no_toc .text-delta }

1. TOC
{:toc}

---

<div id="pharmacist">

## Pharmacist Assessment Report

</div>

# Iron: From an Unrecorded Original Indication to Vitamin B12- and Folate-Independent Constitutional Megaloblastic Anemia

## One-Sentence Summary

Iron is a mineral with six registered products in Singapore, but the registration records do not state an approved indication.
The TxGNN model ranks **vitamin B12- and folate-independent constitutional megaloblastic anemia** as its top prediction, with a very high score.
**No clinical trials and no publications** support this prediction, and the available analysis suggests it is a graph-proximity artifact rather than a real therapeutic signal.

## Quick Overview

| Item | Content |
|------|------|
| Original Indication | Not recorded in the Singapore licence data |
| Predicted New Indication | Vitamin B12- and folate-independent constitutional megaloblastic anemia |
| TxGNN Prediction Score | 99.89% |
| Evidence Level | L5 (model prediction only) |
| Singapore Market Status | ✓ Marketed |
| Number of Registrations | 6 |
| Recommended Decision | Hold |

## Why is This Prediction Reasonable?

Currently, detailed mechanism of action data is not available for iron. The original indication is also missing from the local licence records, so the link between the original and new indication cannot be assessed directly.

The prediction is probably not clinically meaningful. Megaloblastic anemia arises from impaired DNA synthesis, not from iron deficiency. The high TxGNN score most likely reflects the disease's proximity to other anemia nodes in the knowledge graph, not a causal mechanism. Giving iron without a confirmed iron deficit could worsen the picture.

## Clinical Trial Evidence

Currently no related clinical trials registered.

## Literature Evidence

Currently no related literature available.

## Singapore Market Information

Six registrations are on file. Five are shown below. The licence records do not include approved indication text.

| Authorization Number | Product Name | Dosage Form |
|---------|------|------|
| SIN14035P | Ferinject Solution for Injection 50mg/ml | Injection, solution |
| SIN14981P | Maltofer Film-Coated Tablets 100mg | Tablet, film coated |
| SIN16513P | Avofer Injection 100mg/5ml | Injection |
| SIN05699P | Maltofer Drops 50 mg/ml | Solution |
| SIN14727P | Velphoro® Chewable Tablets 500mg | Tablet, chewable |

Available routes: oral and injectable.

## Safety Considerations

Please refer to the package insert for safety information. No drug-interaction records were found.

## Conclusion and Next Steps

**Decision: Hold**

**Rationale:**
The top-ranked prediction has no trials or literature behind it and no plausible mechanism. It is best treated as a model artifact.

Other predicted indications for iron have more support:

| Rank | Predicted Indication | Evidence Level | Note |
|------|------|------|------|
| 2 | Plummer-Vinson syndrome | L4 | 20 publications (reviews and case reports) describe iron repletion as first-line care. No trials or controlled data exist. It is a reasonable research question. |
| 5 | Vitamin deficiency disorder | L2 | Trials mostly test iron deficiency, not the exact mapped term. |
| 10 | Perinatal disease | L2 | Iron-folic acid trials exist in pregnancy. Many test multiple micronutrients, so iron is not isolated. |
| 7 | Injury | L4 | Mixed signal. Iron drives ferroptosis in brain and spinal cord injury, which is a safety concern for neurotrauma. |

**To proceed, the following is needed:**
- Download and parse the HSA package insert to obtain the approved indications, warnings and contraindications (blocking gap).
- Mechanism of action data from DrugBank.
- Confirmation of iron-deficiency status before any iron use for this or any anemia-related indication.
- Consider redirecting the evaluation to Plummer-Vinson syndrome, which has the most credible evidence.
## Disclaimer

This content is for research purposes only and does not constitute medical advice.
Clinical validation is required before any clinical application.

---

